Literature DB >> 14517948

Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot.

Antonio Pizzuti1, Anna Sarkozy, Anthea L Newton, Emanuela Conti, Elisabetta Flex, Maria Cristina Digilio, Francesca Amati, Debora Gianni, Caterina Tandoi, Bruno Marino, Merlin Crossley, Bruno Dallapiccola.   

Abstract

Two out of 47 patients with sporadic tetralogy of Fallot (TOF), the most common cyanotic conotruncal heart defect (CTD), showed heterozygous missense mutations of the ZFPM2/FOG2 gene. Knockout mice carrying mutations in the ZFPM2/FOG2 gene have similarly been found to exhibit TOF. While both mutant ZFPM2/FOG2 proteins, E30G (c.88A>G) and S657G (c.1968A>G), retain the ability to bind the partner protein GATA4 and repress GATA4 mediated gene activation, the S657G, but not the E30G, mutation is subtly impaired in this function. ZFPM2/FOG2 gene mutations may contribute to some sporadic cases of TOF. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517948     DOI: 10.1002/humu.10261

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  37 in total

1.  Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections.

Authors:  Siddharth K Prakash; Scott A LeMaire; Dong-Chuan Guo; Ludivine Russell; Ellen S Regalado; Hossein Golabbakhsh; Ralph J Johnson; Hazim J Safi; Anthony L Estrera; Joseph S Coselli; Molly S Bray; Suzanne M Leal; Dianna M Milewicz; John W Belmont
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

Review 3.  Probing human cardiovascular congenital disease using transgenic mouse models.

Authors:  Paige Snider; Simon J Conway
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 4.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

5.  NRP1 haploinsufficiency predisposes to the development of Tetralogy of Fallot.

Authors:  Ivan Duran; Jessica Tenney; Carmen M Warren; Anna Sarukhanov; Fabiana Csukasi; Mark Skalansky; Maria L Iruela-Arispe; Deborah Krakow
Journal:  Am J Med Genet A       Date:  2018-01-24       Impact factor: 2.802

Review 6.  Genetic testing in congenital heart disease: A clinical approach.

Authors:  Marie A Chaix; Gregor Andelfinger; Paul Khairy
Journal:  World J Cardiol       Date:  2016-02-26

7.  Patterns of cardiac and extracardiac anomalies in adults with tetralogy of fallot.

Authors:  Sara Piran; Anne S Bassett; Jasmine Grewal; Jodi-Ann Swaby; Chantal Morel; Erwin N Oechslin; Andrew N Redington; Peter P Liu; Candice K Silversides
Journal:  Am Heart J       Date:  2011-01       Impact factor: 4.749

Review 8.  What chick and mouse models have taught us about the role of the endocardium in congenital heart disease.

Authors:  Daniel M DeLaughter; Leshana Saint-Jean; H Scott Baldwin; Joey V Barnett
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-04-28

9.  Identification of novel significant variants of ZFPM2/FOG2 in non-syndromic Tetralogy of Fallot and double outlet right ventricle in a Chinese Han population.

Authors:  Xiaomin Huang; Wenquan Niu; Zhen Zhang; Chunxia Zhou; Zhiwei Xu; Jinfen Liu; Zhaokang Su; Wenxiang Ding; Haibo Zhang
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

Review 10.  Molecular genetics of congenital diaphragmatic defects.

Authors:  Malgorzata Bielinska; Patrick Y Jay; Jonathan M Erlich; Susanna Mannisto; Zsolt Urban; Markku Heikinheimo; David B Wilson
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.